Purva Asrani

563 citations
13 papers · 347 indexed · h-index 10
Topics
SARS-CoV-2 and COVID-19 Research (8 papers)COVID-19 Clinical Research Studies (4 papers)Viral gastroenteritis research and epidemiology (2 papers)

In The Last Decade

Purva Asrani

12 papers receiving 343 citations

Peers

Purva Asrani
Comparison fields: 5 of 75
  • Infectious Diseases 202
  • Molecular Biology 72
  • Nutrition and Dietetics 41
  • Food Science 40
  • Modeling and Simulation 40
Replace Pradipta Paul with:
Pradipta Paul Qatar
Firas Rabi Jordan
Alberto Donzelli Italy
Ysrafil Ysrafil Indonesia
Anna Gidari Italy
Sandro G. Viveiros-Rosa Brazil
Qingxing Wang China
Bruno Pradines France
Fuxing Lou China
Purva Asrani relative to Pradipta Paul Qatar Pradipta Paul's profile →
Citations per field
00.5×6.6×
Pradipta Paul · 1×
Citations per year

Countries citing papers authored by Purva Asrani

Since Specialization
Citations

This map shows the geographic impact of Purva Asrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Purva Asrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Purva Asrani more than expected).

Fields of papers citing papers by Purva Asrani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Purva Asrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Purva Asrani. The network helps show where Purva Asrani may publish in the future.

Co-authorship network of co-authors of Purva Asrani

This figure shows the co-authorship network connecting the top 25 collaborators of Purva Asrani. A scholar is included among the top collaborators of Purva Asrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Purva Asrani. Purva Asrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 0
2 17
3 5
4 4
5 23
6 39
7 81
8 17
9 11
10 35
11 41
12 36
13 38

About Purva Asrani

Purva Asrani is a scholar working on Modeling and Simulation, Infectious Diseases and Animal Science and Zoology, having authored 13 papers that have together received 347 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (4 papers) and Viral gastroenteritis research and epidemiology (2 papers). The work is most often cited by research in Infectious Diseases (202 citations), Modeling and Simulation (40 citations) and Nutrition and Dietetics (41 citations). Purva Asrani has collaborated with scholars based in India, Australia and Saudi Arabia. Frequent co-authors include Md. Imtaiyaz Hassan, Sukhwinder Singh Sohal, Mathew Suji Eapen, Gulam Mustafa Hasan, Greg Haug, Taj Mohammad, Dharmendra Kumar Yadav, Alaa Shafie, Farah Anjum and Heinrich C. Weber. Their work appears in journals such as The International Journal of Biochemistry & Cell Biology, The Lancet Respiratory Medicine and Virus Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026